Cargando…

A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene

Lassa virus (LASV) is endemic in Western Africa and is estimated to infect hundreds of thousands of individuals annually. A considerable number of these infections result in Lassa fever (LF), which is associated with significant morbidity and a case-fatality rate as high as 69% among hospitalized co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Yingyun, Ye, Chengjin, Cheng, Benson, Nogales, Aitor, Iwasaki, Masaharu, Yu, Shuiqing, Cooper, Kurt, Liu, David X., Hart, Randy, Adams, Ricky, Brady, Tyler, Postnikova, Elena N., Kurtz, Jonathan, St Claire, Marisa, Kuhn, Jens H., de la Torre, Juan Carlos, Martínez-Sobrido, Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042690/ https://www.ncbi.nlm.nih.gov/pubmed/32098811 http://dx.doi.org/10.1128/mBio.00039-20

Ejemplares similares

CoDe: a web-based tool for codon deoptimization
por: Sharma, Divya, et al.
Publicado: (2023)

A Lassa Virus Live-Attenuated Vaccine Candidate Based on Rearrangement of the Intergenic Region
por: Cai, Yingyun, et al.
Publicado: (2020)

Vaccinia Virus Attenuation by Codon Deoptimization of the A24R Gene for Vaccine Development
por: Lorenzo, María M., et al.
Publicado: (2022)

Reduced Protein Expression in a Virus Attenuated by Codon Deoptimization
por: Jack, Benjamin R., et al.
Publicado: (2017)

ΦX174 Attenuation by Whole-Genome Codon Deoptimization
por: Van Leuven, James T, et al.
Publicado: (2020)

Evaluation of Potential In Vitro Recombination Events in Codon Deoptimized FMDV Strains
por: Spinard, Edward, et al.
Publicado: (2023)

Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody Assays
por: Caì, Yíngyún, et al.
Publicado: (2018)

RCDI/eRCDI: a web-server to estimate codon usage deoptimization
por: Puigbò, Pere, et al.
Publicado: (2010)

Optimization and Deoptimization of Codons in SARS‐CoV‐2 and Related Implications for Vaccine Development
por: Wu, Xinkai, et al.
Publicado: (2023)

Refining the Balance of Attenuation and Immunogenicity of Respiratory Syncytial Virus by Targeted Codon Deoptimization of Virulence Genes
por: Meng, Jia, et al.
Publicado: (2014)

Attenuation of a very virulent Marek's disease herpesvirus (MDV) by codon pair bias deoptimization
por: Eschke, Kathrin, et al.
Publicado: (2018)

Development of a new oral poliovirus vaccine for the eradication end game using codon deoptimization
por: Konopka-Anstadt, Jennifer L., et al.
Publicado: (2020)

Codon Pair Deoptimization (CPD)-Attenuated PRRSV-1 Vaccination Exhibit Immunity to Virulent PRRSV Challenge in Pigs
por: Lee, Min-A, et al.
Publicado: (2023)

Evaluation and Determination of a Suitable Passage Number of Codon Pair Deoptimized PRRSV-1 Vaccine Candidate in Pigs
por: Lee, Min-A, et al.
Publicado: (2023)

An immunotoxin targeting Ebola virus glycoprotein inhibits Ebola virus production from infected cells
por: Cai, Yingyun, et al.
Publicado: (2021)

Lassa virus glycoprotein: stopping a moving target
por: Hastie, Kathryn M, et al.
Publicado: (2018)

Inter-Lineage Variation of Lassa Virus Glycoprotein Epitopes: A Challenge to Lassa Virus Vaccine Development
por: Ibukun, Francis Ifedayo
Publicado: (2020)

Identifying immunodominant multi-epitopes from the envelope glycoprotein of the Lassa mammarenavirus as vaccine candidate for Lassa fever
por: Rowaiye, Adekunle Babajide, et al.
Publicado: (2022)

The Deoptimization of Rabies Virus Matrix Protein Impacts Viral Transcription and Replication
por: Luo, Jun, et al.
Publicado: (2019)

Construction of pseudorabies virus variant attenuated vaccine: codon deoptimization of US3 and UL56 genes based on PRV gE/TK deletion strain
por: Xu, Mengwei, et al.
Publicado: (2023)

Reversion mutations in phosphoprotein P of a codon-pair-deoptimized human respiratory syncytial virus confer increased transcription, immunogenicity, and genetic stability without loss of attenuation
por: Chen, Jessica W., et al.
Publicado: (2021)

Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodies
por: Perrett, Hailee R., et al.
Publicado: (2023)

Reverse Genetics Approaches for the Development of Influenza Vaccines
por: Nogales, Aitor, et al.
Publicado: (2016)

Deoptimization of FMDV P1 Region Results in Robust Serotype-Independent Viral Attenuation
por: Medina, Gisselle N., et al.
Publicado: (2023)

Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection
por: Brouwer, Philip J.M., et al.
Publicado: (2022)

Adjuvants Differentially Modulate the Immunogenicity of Lassa Virus Glycoprotein Subunits in Mice
por: To, Albert, et al.
Publicado: (2022)

Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits
por: Robinson, James E., et al.
Publicado: (2016)

Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine
por: Martínez-Sobrido, Luis, et al.
Publicado: (2018)

Enhanced Efficacy of a Codon-Optimized DNA Vaccine Encoding the Glycoprotein Precursor Gene of Lassa Virus in a Guinea Pig Disease Model When Delivered by Dermal Electroporation
por: Cashman, Kathleen A., et al.
Publicado: (2013)

A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity
por: Cubitt, Beatrice, et al.
Publicado: (2020)

Use of Synonymous Deoptimization to Derive Modified Live Attenuated Strains of Foot and Mouth Disease Virus
por: Diaz-San Segundo, Fayna, et al.
Publicado: (2021)

Identification of Residues in Lassa Virus Glycoprotein Subunit 2 That Are Critical for Protein Function
por: Willard, Katherine A., et al.
Publicado: (2018)

Lassa virus glycoprotein complex review: insights into its unique fusion machinery
por: Pennington, Hallie N., et al.
Publicado: (2022)

Deletion of the first glycosylation site promotes Lassa virus glycoprotein-mediated membrane fusion
por: Dong, Siqi, et al.
Publicado: (2023)

A Broad and Potent H1-Specific Human Monoclonal Antibody Produced in Plants Prevents Influenza Virus Infection and Transmission in Guinea Pigs
por: Park, Jun-Gyu, et al.
Publicado: (2020)

Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use
por: Nogales, Aitor, et al.
Publicado: (2022)

Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects
por: Branco, Luis M, et al.
Publicado: (2010)

Acidic pH-Induced Conformations and LAMP1 Binding of the Lassa Virus Glycoprotein Spike
por: Li, Sai, et al.
Publicado: (2016)

Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteins
por: Wang, Min, et al.
Publicado: (2017)

Effects of N-Linked Glycan on Lassa Virus Envelope Glycoprotein Cleavage, Infectivity, and Immune Response
por: Zhu, Xueqin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s3mlk3m77q5apjlgr7q6n9ehm5